Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 140Leukemia, Myeloid, Acute 120Leukemia 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Myeloproliferative Disorders 57Lymphoma 56Lymphoma, Non-Hodgkin 55Leukemia, Lymphocytic, Chronic, B-Cell 53Leukemia, Myeloid, Chronic-Phase 52Multiple Myeloma 51Leukemia, Myelomonocytic, Chronic 50Hodgkin Disease 49Congenital Abnormalities 47Leukemia, Myeloid, Accelerated Phase 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Primary Myelofibrosis 40Blast Crisis 39Anemia, Refractory, with Excess of Blasts 38Lymphoma, Follicular 37Lymphoma, Large B-Cell, Diffuse 36Lymphoma, Mantle-Cell 35Burkitt Lymphoma 35Myelodysplastic-Myeloproliferative Diseases 34Lymphoma, B-Cell, Marginal Zone 33Neoplasms, Plasma Cell 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 31Graft vs Host Disease 24Dendritic Cell Sarcoma, Interdigitating 23Polycythemia Vera 21

Interventions

fludarabine 2Tacrolimus 2fludarabine phosphate 1Whole-Body Irradiation 1Stem Cell Transplantation 1Mycophenolic Acid 1Cyclophosphamide 1Busulfan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraproteinemias × Busulfan × Myeloid × Clear all
NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡